However, all clinicopathological features mentioned above had no statistical significance between HER2-low BCs and Her2-0 BCs, irrespective of HR status, as well as the factors of tumor location, breast surgery type, T stage, TNM stage, PR, Ki-67 and AR. The gene discussed is ERBB2; the disease is neoplasm.